| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 28,83% | 34,27% | -21,55% | · |
| JPM EMERGING MARKETS EQUITY I2 (DIST) EUR | RVI EMERGENTES | 28,83% | 62,93% | 21,26% | · |
| JPM EMERGING MARKETS EQUITY I (DIST) EUR | RVI EMERGENTES | 28,83% | 62,49% | 20,85% | · |
| T.ROWE EMERGING MARKETS DISCOVERY EQUITY FUND I | RVI EMERGENTES | 28,83% | 73,68% | 61,41% | 150,69% |
| BNP PARIBAS ASIA EX-JAPAN EQUITY PRIVILEGE USD CAP | RVI ASIA EX-JAPÓN CRECIMIENTO | 28,82% | 71,47% | 37,05% | 102,77% |
| LO FUNDS - TARGETNETZERO EMERGING MARKETS EQUITY SEED (EUR) P CAP | RVI EMERGENTES | 28,82% | 73,93% | 7,09% | 1,42% |
| PICTET - EMERGING MARKETS INDEX J USD | RVI EMERGENTES | 28,82% | 74,58% | 49,95% | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP EUR | RVI BIOTECNOLOGÍA | 28,81% | 66,67% | 68,92% | 187,76% |
| ALLIANZ ORIENTAL INCOME IT EUR | MIXTO MODERADO GLOBAL | 28,80% | 66,65% | 59,97% | · |
| BLACKROCK SYSTEMATIC US EQUITY ABSOLUTE RETURN X2 USD | RENT. ABSOLUTA. | 28,80% | 37,06% | 80,09% | · |
